schaak ik ontbijt rietje non ligand estrogen pathway nf kappa fulvestrant Kritiek ventilator helpen
Transcriptional repression of estrogen receptor alpha by YAP reveals the Hippo pathway as therapeutic target for ER+ breast cancer | Nature Communications
Four major mechanisms of estrogen and estrogen receptors (ER). (I)... | Download Scientific Diagram
Cancers | Free Full-Text | Classical and Non-Classical Progesterone Signaling in Breast Cancers | HTML
Estradiol Suppresses NF-κB Activation through Coordinated Regulation of let-7a and miR-125b in Primary Human Macrophages | The Journal of Immunology
Targeted degradation of activating estrogen receptor α ligand-binding domain mutations in human breast cancer | SpringerLink
A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and Genomic Signaling.,Cell Chemical Biology - X-MOL
Full antagonism of the estrogen receptor without a prototypical ligand side chain | Nature Chemical Biology
Regulation of estrogen receptor signaling in breast carcinogenesis and breast cancer therapy. - Abstract - Europe PMC
Potentiation of ICI182,780 (Fulvestrant)-induced Estrogen Receptor-α Degradation by the Estrogen Receptor-related Receptor-α Inverse Agonist XCT790* - Journal of Biological Chemistry
Targeting Androgen/Estrogen Receptors Crosstalk in Cancer: Trends in Cancer
Molecular mechanism of estrogen–estrogen receptor signaling - Yaşar - 2017 - Reproductive Medicine and Biology - Wiley Online Library
Estrogen receptor functional domains and signal transduction schemes.... | Download Scientific Diagram
Frontiers | G Protein-Coupled Estrogen Receptor: A Potential Therapeutic Target in Cancer | Endocrinology
Targeted degradation of activating estrogen receptor α ligand-binding domain mutations in human breast cancer | SpringerLink
Regulation of estrogen receptor signaling in breast carcinogenesis and breast cancer therapy. - Abstract - Europe PMC
Cancers | Free Full-Text | Natural and Synthetic Estrogens in Chronic Inflammation and Breast Cancer | HTML
Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action | British Journal of Cancer
Targeting estrogen receptor α for degradation with PROTACs: A promising approach to overcome endocrine resistance - ScienceDirect
Estrogen/ER in anti-tumor immunity regulation to tumor cell and tumor microenvironment - Abstract - Europe PMC
Frontiers | Estrogen Signaling in ERα-Negative Breast Cancer: ERβ and GPER | Endocrinology
Frontiers | Non-canonical Estrogen Signaling in Endocrine Resistance | Endocrinology
Targeted degradation of activating estrogen receptor α ligand-binding domain mutations in human breast cancer | SpringerLink
Activation of Transcription by Estrogen Receptor α and β Is Cell Type- and Promoter-dependent* - Journal of Biological Chemistry